Post quarterly results, the consensus target on the scrip stays at Rs 2,881, similar to Rs 2,880 before earnings, with 80 per cent of recommendations suggesting a buy, 13 per cent hold and 7 per cent sell on the stock. The target suggests a potential 20 per cent upside for the stock.
Valuations turn attractive as markets look beyond uncertainty: A Balasubramanian
Amidst geopolitical uncertainty, market expert A Balasubramanian suggests the worst may be nearing an end, with improving macro signals and reasonable valuations in Indian equities.
April 10, 2026